|
EP0922765B1
(en)
*
|
1997-12-02 |
2005-11-23 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
EP0921196A1
(en)
*
|
1997-12-02 |
1999-06-09 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
US20050123940A1
(en)
*
|
1999-10-29 |
2005-06-09 |
Stratagene California |
Compositions and methods for synthesizing cDNA
|
|
US20030228616A1
(en)
*
|
1999-10-29 |
2003-12-11 |
Stratagene |
DNA polymerase mutants with reverse transcriptase activity
|
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
|
DE60231901D1
(de)
*
|
2001-11-14 |
2009-05-20 |
Toyo Boseki |
Dna-synthesepromotoren, mit dna-polymerase assoziierte faktoren und nutzung davon
|
|
KR20070121853A
(ko)
|
2003-03-31 |
2007-12-27 |
에프. 호프만-라 로슈 아게 |
일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법
|
|
WO2005090968A1
(en)
|
2004-03-16 |
2005-09-29 |
Inist Inc. |
Tat-based immunomodulatory compositions and methods of their discovery and use
|
|
US8962293B2
(en)
|
2006-10-18 |
2015-02-24 |
Roche Molecular Systems, Inc. |
DNA polymerases and related methods
|
|
AU2010230073B2
(en)
|
2009-03-23 |
2016-05-26 |
Pin Pharma, Inc. |
Treatment of cancer with immunostimulatory HIV Tat derivative polypeptides
|
|
US8722378B2
(en)
|
2010-06-18 |
2014-05-13 |
Roche Molecular Systems, Inc. |
DNA polymerases with increased 3′-mismatch discrimination
|
|
CA2802000C
(en)
|
2010-06-18 |
2016-08-16 |
F. Hoffmann-La Roche Ag |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CN103025870B
(zh)
|
2010-06-18 |
2015-07-01 |
霍夫曼-拉罗奇有限公司 |
具有增强的3’-错配辨别力的dna聚合酶
|
|
CN103025867B
(zh)
|
2010-06-18 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
具有增强的3’-错配辨别力的dna聚合酶
|
|
JP5876479B2
(ja)
|
2010-06-18 |
2016-03-02 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
増大した３’末端ミスマッチ識別を有するｄｎａポリメラーゼ
|
|
ES2536252T3
(es)
|
2010-06-18 |
2015-05-21 |
F. Hoffmann-La Roche Ag |
ADN polimerasas con diferenciación de desapareamientos 3' aumentada
|
|
JP5926248B2
(ja)
|
2010-06-18 |
2016-05-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
増大した３’末端ミスマッチ識別能を有するｄｎａポリメラーゼ
|
|
JP5841136B2
(ja)
|
2010-06-18 |
2016-01-13 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
増大した３’末端ミスマッチ識別能を有するｄｎａポリメラーゼ
|
|
EP2675897B1
(en)
|
2011-02-15 |
2016-05-11 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CA2831180C
(en)
|
2011-04-11 |
2017-02-14 |
Keith Bauer |
Dna polymerases with improved activity
|
|
JP6378085B2
(ja)
|
2011-07-28 |
2018-08-22 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
改善された活性を有するｄｎａポリメラーゼ
|
|
EP2788479B1
(en)
|
2011-12-08 |
2016-02-10 |
Roche Diagnostics GmbH |
Dna polymerases with improved activity
|
|
WO2013083262A1
(en)
|
2011-12-08 |
2013-06-13 |
Roche Diagnostics Gmbh |
Dna polymerases with improved activity
|
|
CN103987843B
(zh)
|
2011-12-08 |
2015-12-23 |
霍夫曼-拉罗奇有限公司 |
具有改进活性的dna聚合酶
|
|
EP3052127A1
(en)
|
2013-10-04 |
2016-08-10 |
PIN Pharma, Inc. |
Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment
|
|
US12043851B2
(en)
|
2018-03-21 |
2024-07-23 |
Roche Molecular Systems, Inc. |
DNA polymerases for efficient and effective incorporation of methylated-dNTPS
|
|
JP7504872B2
(ja)
|
2018-09-13 |
2024-06-24 |
エフ． ホフマン－ラ ロシュ アーゲー |
改善されたストランド置換能力を有する変異体ｄｎａポリメラーゼ
|
|
CN111733145A
(zh)
*
|
2020-07-01 |
2020-10-02 |
济南国科医工科技发展有限公司 |
重组酶的纯化方法
|